Skip to main content
Mochida Pharmaceutical Co.,Ltd. logo

Mochida Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 4534 ISIN · JP3922800002 LEI · 3538008YGVRYRM8B7Q95 T Manufacturing
Open in API
Filings indexed 58 across all filing types
Latest filing 2018-11-09 Interim / Quarterly Rep…
Country JP Japan
Listing T 4534

About Mochida Pharmaceutical Co.,Ltd.

https://www.mochida.co.jp/english/

Mochida Pharmaceutical Co., Ltd. is a research-driven company focused on the development, manufacturing, and sale of pharmaceuticals, healthcare products, and medical devices. The company's core pharmaceutical business concentrates on therapeutic areas such as cardiovascular diseases, with a key focus on circulatory agents. It is also active in other fields, including oncology, through partnerships for generic products. In its healthcare segment, Mochida develops and markets functional, low-irritating products based on dermatological science. Additionally, the company distributes medical instruments and equipment for diagnostic and surgical applications, contributing to a broad spectrum of medical care.

Recent filings

Filing Released Lang Actions
四半期報告書－第81期第2四半期(2018/07/01－2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Mochida Pharmaceutical Co., Ltd. for the second quarter of the 81st fiscal period. It contains detailed financial statements, management analysis (MDA), and business information. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). Q2 2019
2018-11-09 Japanese
四半期報告書－第81期第1四半期(2018/04/01－2018/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MDA), and business information for the first quarter of the 81st fiscal period (April 1, 2018, to June 30, 2018). As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. Q1 2019
2018-08-10 Japanese
有価証券報告書－第80期(平成29年4月1日－平成30年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains comprehensive financial data, including consolidated and non-consolidated financial indicators, historical performance, and corporate history for the fiscal year ending March 31, 2018. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau. FY 2018
2018-06-28 Japanese
四半期報告書－第80期第3四半期(2017/10/01－2017/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis of financial results (MDA), and business performance data for the third quarter of the 80th fiscal period. It is a comprehensive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report. 9M 2018
2018-02-09 Japanese
四半期報告書－第80期第2四半期(2017/07/01－2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, covering the second quarter of the 80th fiscal period (April 1, 2017 to September 30, 2017). It contains detailed financial statements, management analysis of financial conditions, and business results. This matches the definition of an Interim/Quarterly Report (IR). Q2 2018
2017-11-10 Japanese
四半期報告書－第80期第1四半期(2017/04/01－2017/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Mochida Pharmaceutical Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis (MD&A), and business performance data for the first quarter of the 80th fiscal year (April 1, 2017 to June 30, 2017). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2018
2017-08-10 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.